ArticleFrontiers in oncology2026

Selinexor enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by regulating the BAX/Bcl-2/PUMA apoptotic pathway and the XPO1/p27 cell cycle pathway.

Shenghong Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.